Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Pension (2016 - 2019)

Historic Pension for Harvard Bioscience (HBIO) over the last 11 years, with Q2 2019 value amounting to $900000.0.

  • Harvard Bioscience's Pension fell 2500.0% to $900000.0 in Q2 2019 from the same period last year, while for Jun 2019 it was $900000.0, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of $900000.0 for FY2018, which is 2500.0% down from last year.
  • According to the latest figures from Q2 2019, Harvard Bioscience's Pension is $900000.0, which was down 2500.0% from $900000.0 recorded in Q4 2018.
  • In the past 5 years, Harvard Bioscience's Pension ranged from a high of $4.6 million in Q2 2015 and a low of $900000.0 during Q4 2018
  • Its 5-year average for Pension is $2.6 million, with a median of $2.8 million in 2015.
  • Its Pension has fluctuated over the past 5 years, first surged by 3076.92% in 2017, then tumbled by 6470.59% in 2018.
  • Over the past 5 years, Harvard Bioscience's Pension (Quarter) stood at $2.8 million in 2015, then increased by 7.14% to $3.0 million in 2016, then crashed by 60.0% to $1.2 million in 2017, then decreased by 25.0% to $900000.0 in 2018, then changed by 0.0% to $900000.0 in 2019.
  • Its Pension was $900000.0 in Q2 2019, compared to $900000.0 in Q4 2018 and $1.2 million in Q3 2018.